FDA Approves Ebglyss for Moderate-to-Severe Atopic Dermatitis

Monthly News Roundup - October 2024

drugs.com - 31/Oct 00:10

FDA Approves AbbVie’s Vyalev to Treat Advanced Parkinson Disease In October, the US Food and Drug Administration (FDA) approved Vyalev...

FDA Approves Orlynvah (sulopenem etzadroxil and probenecid) for the Treatment of Uncomplicated Urinary Tract Infections

drugs.com - 25/Oct 21:10

DUBLIN and CHICAGO, Oct. 25, 2024 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (Iterum), today announced that the U.S. Food and Drug...

Long-Term Upadacitinib Use Feasible for Adolescents With Atopic Dermatitis

drugs.com - 25/Oct 20:32

FRIDAY, Oct. 25, 2024 -- Long-term treatment of adolescents with moderate-to-severe atopic dermatitis (AD) with upadacitinib is safe and effective...

Lexicon Announces Outcome of FDA Advisory Committee for Zynquista (sotagliflozin) as an Adjunct to Insulin Therapy for Glycemic Control in Adults with Type 1 Diabetes and Chronic Kidney Disease

drugs.com - 31/Oct 21:10

THE WOODLANDS, Texas, October 31, 2024 -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced the outcome of the U.S. Food and Drug...

Shorla Oncology Announces U.S. FDA Expanded Approval of Jylamvo (methotrexate), an Oncology and Autoimmune Drug for Pediatric Indications

drugs.com - 29/Oct 10:10

CAMBRIDGE, Mass.--(BUSINESS WIRE) October 29, 2024 --Shorla Oncology (‘Shorla’), a U.S.-Ireland specialty pharmaceutical company,...

Abeona Therapeutics Completes Pz-cel Biologics License Application Resubmission to U.S. Food and Drug Administration

drugs.com - 29/Oct 22:10

CLEVELAND, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that the Company has resubmitted its Biologics...

Ionis Announces FDA Acceptance of New Drug Application for Donidalorsen for Prophylactic Treatment of HAE

drugs.com - 04/Nov 23:11

CARLSBAD, Calif., Nov. 4, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that the U.S. Food and Drug Administration...

PTC Therapeutics Announces FDA Acceptance of Translarna NDA Resubmission

drugs.com - 30/Oct 05:10

WARREN, N.J., Oct. 30, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today the U.S. Food and Drug Administration (FDA) has...

FDA Approves Emrosi (minocycline hydrochloride) for the Treatment of Rosacea

drugs.com - 04/Nov 00:11

SCOTTSDALE, Ariz., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical”), a commercial-stage...

Do Elimination Diets Really Help Kids With Eczema?

medindia.net - 27/Oct 16:39

Parents of children with atopic dermatitis (eczema) sometimes consider elimination diets to lower food allergy risks. However, a new study reveals...

Rubriques :